NGD PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
NGD PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
Not calculatedReliability
Prescore cannot be calculated due to significantly decreased turnover, expert evaluation needed.
Incorporation date
24/04/2019Share capital
51,400.00 PLNPrimary activity
Research and experimental development on biotechnology (72.11.Z - PKD 2007)Representatives
0Representatives rights
W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO OŚWIADCZENIA W IMIENIU SPÓŁKI SKŁADA CZŁONEK ZARZĄDU. W PRZYPADKU ZARZĄDU SKŁADAJĄCEGO SIĘ Z DWÓCH LUB WIĘKSZEJ LICZBY OSÓB DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI JEST WYMAGANE WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
-5,087Net Profit (zł)
-5,087Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 0 |
| -131,574 |
| -131,574 |
| - |
| 41.31 |
| - |
| 61,390 |
| 851 |
| 0 |
| - |
| 2023 |
|---|
| 0 |
| -43,178 |
| -43,178 |
| - |
| 22.40 |
| - |
| 18,212 |
| 851 |
| 0 |
| 22,699 |
| 2024 |
|---|
| 1,000 |
| -5,087 |
| -5,087 |
| 13.13 |
| - |
| -508.70 |
| 13,126 |
| 0 |
| 0 |
| 0 |
| 2024 |
|---|
| 1,000 |
| -5,087 |
| -5,087 |
| 13.13 |
| - |
| -508.70 |
| 13,126 |
| 0 |
| 0 |
| 0 |
Turnover (zł)
2024
Turnover (zł)
1,000 zł
- *
Profit before tax (zł)
-5,087 zł
88 % *
Net Profit (zł)
-5,087 zł88 % *
Working capital requirement (%)
13.13 - *
Liquidity ratio
-Net profitability (%)
-508.70 %- *
Equity (zł)
13,126 zł
-28 % *
Current liabilities (zł)
0 zł-100 % *
Non current liabilities (zł)
0 zł- *
Non-current Assets (zł)
0 zł
-100 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
NGD PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
22/07/2025 | OD 01.01.2023 DO 31.12.2023 |
22/07/2025 | OD 01.01.2024 DO 31.12.2024 |
17/07/2023 | OD 01.01.2022 DO 31.12.2022 |
13/09/2022 | OD 01.01.2021 DO 31.12.2021 |
24/06/2021 | OD 01.01.2020 DO 31.12.2020 |